Cancer rehabilitation into the future

The 5‐year survival for many cancer sites exceeds 50%, suggesting that these patients are living longer and may be considered to have a chronic illness. The incidence of cancer increases from 500 in 100,000 to 2000–4000 in 100,000 as women or men age from 50 to 80 years. Our population is aging and the prevalence of cancer is increasing. Treatments for cancer are quite complex, and they are often delivered to elders who have a variety of medical problems and are receiving additional medications that may complicate overall patient management. Hence, these patients may have extremely complex functional problems. Cancer patients need comprehensive care designed to relieve symptoms of pain, fatigue, and weakness. They need education to help support their ability to reach functional independence and maintain quality of life. Rehabilitation professionals are essential for the comprehensive care of cancer patients throughout the phases of their disease: treatment planning, treatment, remission, recurrence, and end of life. The needs of this population can better be served if several processes are put into effect. Rehabilitation professionals must be trained to manage problems associated with cancer and its treatments. Research about what are effective and efficient rehabilitation treatments must be done to determine how best to treat cancer patients throughout the various phases of their illness. Physicians and patients must be alerted to the importance of rehabilitation interventions to the overall function of these patients. Cancer 2001;92:975–9. © 2001 American Cancer Society.

[1]  W. Raub From the National Institutes of Health. , 1990, JAMA.

[2]  A. Gafni,et al.  The supportive care needs of newly diagnosed cancer patients attending a regional cancer center , 1997, Cancer.

[3]  A McMurray,et al.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. M. Lindsey,et al.  Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. , 1992, Oncology nursing forum.

[6]  A. Heinemann,et al.  Functional outcome following rehabilitation of the cancer patient. , 1996, Archives of physical medicine and rehabilitation.

[7]  C G Warren,et al.  Cancer rehabilitation: assessment of need, development, and evaluation of a model of care. , 1978, Archives of physical medicine and rehabilitation.

[8]  L. Derogatis,et al.  Psychological coping mechanisms and survival time in metastatic breast cancer. , 1979, JAMA.

[9]  R. Sanson-Fisher,et al.  Measuring quality of life in cancer patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  V. Mor,et al.  Clinical symptoms and length of survival in patients with terminal cancer. , 1988, Archives of internal medicine.

[11]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[12]  J Keul,et al.  Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. , 1997, Blood.

[13]  M. Macvicar,et al.  Effects of Aerobic Interval Training on Cancer Patients' Functional Capacity , 1989, Nursing research.

[14]  F. Dimeo,et al.  Aerobic exercise as therapy for cancer fatigue. , 1998, Medicine and science in sports and exercise.

[15]  F. Finkelman,et al.  Exercise-induced changes in populations of peripheral blood mononuclear cells. , 1988, Medicine and science in sports and exercise.